IKT Competitors & Alternatives
Compare Inhibikase Therapeutics Inc with similar stocks in the same industry
Biotechnology
IKT
Main Stock$1.99
Tradestie Score
53
Market Cap
$119.97M
Revenue Growth
-1.0%
Analyst Upside
+195.2%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.51
|
$297.23M | - | 58 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$37.93
|
$293.03M | - | 64 | Compare |
|
OMER
Omeros Corporation
|
$9.28
|
$281.75M | 8.3 | 51 | Compare |
|
DBVT
DBV Technologies S.A.
|
$15.82
|
$275.54M | - | 55 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.08
|
$275.13M | - | 55 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$20.59
|
$269.08M | - | 57 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.89
|
$258.18M | - | 59 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$35.34
|
$256.54M | - | 64 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$14.98
|
$211.22M | - | 54 | Compare |
More IKT Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2836)
236 stocks in this industry